Comparison of insulin glargine vs standard insulin therapy [bedtime insulin suspension isophane] in CFRD [cystic fibrosis-related diabetes] without fasting hyperglycemia.
Phase of Trial: Phase III
Latest Information Update: 15 Dec 2009
At a glance
- Drugs Insulin glargine; Insulin suspension isophane
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Aug 2007 The expected completion date for this trial is now 1 Aug 2005.
- 19 Sep 2006 New trial record.